OLAPARIB DOSE REDUCTION IN PLATINUM-SENSITIVE OVARIAN CANCER RECURRENCE: REAL-WORLD DATA

被引：0
|
作者：
Boccia, Serena Maria [1 ]
Culcasi, Camilla [1 ]
Sassu, Carolina Maria [1 ]
Guida, Fiorenza [1 ]
Apostol, Adriana Ionelia [1 ]
Vertechy, Laura [1 ]
Ferrandina, Gabriella [1 ,2 ]
Fagotti, Anna [1 ,2 ]
Scambia, Giovanni [1 ,2 ]
Marchetti, Claudia [1 ,2 ]
机构：
[1] IRCCS, Dipartimento Sci Salute Donna Bambino & Sanit Pu, Fdn Policlin Univ Agostino Gemelli, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dipartimento Sci Vita & Sanit Pubbl, Rome, Italy
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷
关键词：
D O I：
10.1136/ijgc-2023-ESGO.668
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
887
引用
收藏
页码：A319 / A319
页数：1
相关论文
共 50 条
  • [41] MANAGEMENT OF FIRST RELAPSE IN PLATINUM-SENSITIVE OVARIAN CANCER
    Vieira, C.
    Teixeira, A.
    Vaz, A.
    Ferreira, A.
    Oliveira, J.
    Couto, R.
    Afonso, N.
    Sousa, S.
    Sousa, B.
    Pereira, D.
    ANNALS OF ONCOLOGY, 2008, 19 : 215 - 215
  • [42] Randomized phase II CLIO study on olaparib monotherapy versus chemotherapy in platinum-sensitive recurrent ovarian cancer
    Loverix, L.
    Vanderstichele, A.
    Olbrecht, S.
    Van Niewenhuysen, E.
    Van Gorp, T.
    Han, S. N.
    Salihi, R.
    Concin, N.
    Neven, P.
    Busschaert, P.
    Lambrechts, D.
    Vergote, I.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 17 - 18
  • [43] DESENSITIZATION THERAPY FOLLOWED BY OLAPARIB FOR PATIENTS WITH PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER WHO HAD PLATINUM HYPERSENSITIVITY: A CASE REPORT
    Hori, K.
    Yagi, T.
    Tomohiko, T.
    Saori, T.
    Ohkubo, R.
    Michiko, Y.
    Hiromasa, K.
    Mayako, G.
    Tomohiko, T.
    Lena, T.
    Kimihiko, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 704 - 704
  • [44] Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer (SOC) and a BRCA mutation (BRCAm)
    Ledermann, Jonathan A.
    Harter, Philipp
    Gourley, Charlie
    Friedlander, Michael
    Vergote, Ignace
    Rustin, Gordon J. S.
    Scott, Clare L.
    Meier, Werner
    Shapira-Frommer, Ronnie
    Safra, Tamar
    Matei, Daniela
    Fielding, Anitra
    Macpherson, Euan
    Dougherty, Brian
    Juergensmeier, Juliane M.
    Orr, Maria
    Matulonis, Ursula
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] Advances in the Management of Platinum-Sensitive Relapsed Ovarian Cancer
    Bouberhan, Sara
    Pujade-Lauraine, Eric
    Cannistra, Stephen A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27) : 2424 - +
  • [46] Increasing the chances for platinum-sensitive ovarian cancer patients
    Gonzalez, Antonio
    FUTURE ONCOLOGY, 2013, 9 (12) : 29 - 35
  • [47] Olaparib treatment in older patients with ovarian cancer: need for 'real-world' data beyond clinical trials
    Liposits, Gabor
    Wulff, Christian Nielsen
    Otland, Anne
    Fokdal, Lars Ulrik
    ECANCERMEDICALSCIENCE, 2020, 14
  • [48] The role of bevacizumab in recurrent, platinum-sensitive ovarian cancer
    Gubbi, Ajit
    Kendrick, James E.
    Finkler, Neil J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (10) : 1105 - 1113
  • [49] Efficacy and safety of olaparib in the treatment of platinum-sensitive recurrent ovarian cancer: a systematic review and meta-analysis
    Wang, Yan
    Cai, Yan
    Wang, Qiming
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2022, 43 (03) : 46 - 52
  • [50] Cost-effectiveness analysis of olaparib and niraparib as maintenance therapy for women with recurrent platinum-sensitive ovarian cancer
    Leung, John Hang
    Lang, Hui-Chu
    Wang, Shyh-Yau
    Lo, Hsueh Fang
    Chan, Agnes L. F.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (03) : 489 - 496
12345